MedTrace Logo

Outreach for Diabetes Cure

NCT01384045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2800

Last updated 2012-12-18

No results posted yet for this study

Summary

Using a socioeconomic, race/ethnic, and gender-diverse sample of patients who receive diabetes care from a University of Colorado Hospital (UCH) primary care provider (PCP), carry out a randomized-controlled trial of usual care versus an outreach intervention designed to increase guideline concordance with American Diabetes Association (ADA) recommendations for blood pressure, Low-density lipoprotein (LDL), and glycosylated hemoglobin (A1c) goals, referrals for retinal exams, and aspirin therapy.Primary hypotheses: The proportion of patients meeting goal will be 10% higher in the intervention compared with control group in the following domains: 1. LDL\<100 mg/dL; 2. A1c\<7.0%; and 3. Systolic blood pressure\<130 mm Hg or diastolic blood pressure\<80 mm Hg.

Conditions

  • Type II Diabetes

Interventions

OTHER

Health promotion outreach

Calling patients who are due for diabetes related services, sending them an interventional letter and assisting them in getting over due serves.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Steven Ross, MD · University of Colorado, Denver

  • Razzaghi Mitra, MD · University of Colorado, Denver

  • Lobo Ingrid, MD · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01384045 on ClinicalTrials.gov